AstraZeneca signs up to $555 million deal with US-based Algen to develop gene therapies

Algen Biotechnologies said on Monday it has agreed to grant AstraZeneca a license to develop gene therapies the U.S.-based biotech discovers using its artificial intelligence-driven platform, in a dea... ...